Duality Advisers, LP Karuna Therapeutics, Inc. Transaction History

Duality Advisers, LP

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023
BUY
$164.66 - $218.08 $638,880 - $846,150
3,880 New
3,880 $656,000
Q1 2023

Jun 27, 2023
SELL
$161.33 - $204.36 $448,658 - $568,325
-2,781 Reduced 19.94%
11,169 $2.03 Million
Q4 2022

Feb 07, 2023
BUY
$191.53 - $236.82 $334,219 - $413,250
1,745 Added 14.3%
13,950 $2.74 Million
Q3 2022

Nov 03, 2022
BUY
$123.79 - $277.42 $1.51 Million - $3.39 Million
12,205 New
12,205 $2.75 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email